Xcout IntelSign inSubscribe

Aptahem

BiotechSweden

Aptahem AB is a clinical-stage biotechnology company that develops RNA-based pharmaceuticals, also known as aptamers, for the treatment of acute conditions such as sepsis.

Subscribe to see Aptahem’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Aptahem at a glance

Aptahem is a biotech company headquartered in Sweden. Its most recent funding round raised $1.5M in September 2026. Xcout tracks 1 named person at Aptahem, including Mikael Lindstam (vd).

As of 16 November 2026. Source: Xcout Intel.

Industry
Biotech
Headquarters
Sweden

Aptahem leadership

  • Mikael Lindstamvd

Aptahem funding rounds

Every round on record:

DateRoundAmountInvestors
—$1.5M—

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Recent Aptahem news

Aptahem competitors

A few of Aptahem's closest competitors — see the full list of competitors and alternatives →

Get Aptahem's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Something wrong or missing about Aptahem? Suggest a correction · Work at Aptahem? Claim this profile

Is this your company? Add the Xcout Intel badge to your website

Free, for any company on Xcout Intel. It links visitors to this profile.

Aptahem on Xcout Intel

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Aptahem — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Aptahem in Xcout Intel

  • 1 named person with titles, LinkedIn and board committees
  • 1 funding round with the investors in each, and who they co-invest with
  • 1 corporate event with sources — deals, leadership changes, layoffs
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →